CTCBIO Inc. (KOSDAQ:A060590) announced a private placement of series 2 unregistered unguaranteed private convertible bonds for gross proceeds of KRW 21,000,000,000 on October 2, 2018. The transaction will involve participation from NH Investment & Securities Co., Ltd. for KRW 3,000,000,000; Kiwoom Securities Co., Ltd. for KRW 4,000,000,000; KB Securities Co., Ltd. on behalf of NH Absolute Return Hedge Fund 1st unit for KRW 2,000,000,000; Mirae Asset Daewoo Co., Ltd. on behalf of GVA Fortress-A Hedge Fund, GVA Saber-G Hedge Fund and GVA KOSDAQ Venture Hedge Fund for KRW 2,900,000,000; Yen H Investments Securities Corporation on behalf of GVA KOSDAQ IPO-I Hedge Fund for KRW 500,000,000; Shinhan Investment Corp. on behalf of Timefolio The Time-M2 Hedge Fund, Timefolio The Time-A2 Hedge Fund, Timefolio The Time-T2 Hedge Fund, Timefolio The Venture-V Hedge Fund, Timefolio KOSDAQ Venture Quant-I Hedge Fund for KRW 3,300,000,000; and Samsung Securities Co.,Ltd. on behalf of NH Absolute Pre IPO Mezzanine Hedge Fund 1, GVA Fortress-V Hedge Fund, GVA Saber-E Hedge Fund, GVA Mezz-V Hedge Fund, Timefolio The Time-A Hedge Fund, Timefolio The Venture-G Hedge Fund and Timefolio KOSDAQ Venture Hedge-S Fund for KRW 5,300,000,000.

The bonds will have no coupon rate and yield to maturity of 2% each maturing on October 4, 2023. The bonds will be fully convertible into 1,621,621 shares of the company at a fixed conversion price of KRW 12,950 per share from October 4, 2019 to September 4, 2023. The subscription and payment date of the transaction is October 4, 2018.

The transaction was approved by the board of directors of the company.